LeafNLP Demos
Back to explore

Report #2882650

Received Jan 21, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
Jul 28, 2025
Onset
Jan 15, 2026
Days to onset
171
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.1——
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.2——
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.3——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No additional AE reported; an adult patient was at the facility for their first dose on 28JUL2025, their second dose on 04SEP2025, and that they were at the facility today, 15JAN2026, for their third dose.; This spontaneous report was received from a Physician Assistant and refers to an Adult patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 28-Jul-2025, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), Suspension for injection, dose number 1, (lot # and expiration date were not reported) for prophylaxis. On 04-Sep-2025, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), Suspension for injection, dose number 2, (lot # and expiration date were not reported) for prophylaxis. On 15-Jan-2026, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), Suspension for injection, dose number 3, (lot # and expiration date were not reported) for prophylaxis (Inappropriate schedule of product administration). No additional AE reported (no adverse event). Lot # is being requested and will be submitted if received.